×
About 1,795 results

ALLMedicine™ Castleman Disease Center

Research & Reviews  883 results

UCD with MCD-like inflammatory state: surgical excision is highly effective.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805307
Blood Advances; Zhang MY, Jia MN et. al.

Feb 11th, 2021 - Unicentric Castleman disease (UCD) is a rare lymphoproliferative disorder presenting as a single nodal mass with characteristic histopathology. Patients with UCD are typically asymptomatic with normal laboratory markers, whereas patients with mult...

Coexistence of disseminated Kaposi sarcoma and multicentric Castleman disease in an HIV...
https://doi.org/10.1177/0956462420968385
International Journal of STD & AIDS; Lin IF, Lin JN et. al.

Feb 8th, 2021 - Coexistence of multicentric Castleman disease and Kaposi sarcoma is rare and might be missed without an experienced pathologists' interpretation. A 46-year-old man had been diagnosed with HIV infection and treated with combination antiretroviral t...

Adult Langerhans cell histiocytosis of skull in a patient with synchronous papillary th...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839860
BMJ Case Reports; Kim IK, Lee KY

Jan 26th, 2021 - We report an extremely rare case of adult Langerhans cell histiocytosis (LCH) in a patient with papillary thyroid carcinoma (PTC) and Castleman disease (CD). A 46-year-old man visited our hospital with anaemia; systemic imaging showed an abdominal...

Cutaneous Involvement as Initial Presentation of Multicentric Plasmacytic Castleman Dis...
https://doi.org/10.1111/cup.13964
Journal of Cutaneous Pathology; Chen H, Ba W et. al.

Jan 20th, 2021 - Castleman disease (CD) is an unusual lymphoproliferative disorder characterized by multiple lymphadenopathy accompanied by marked systemic inflammatory symptoms. CD can be unicentric (UCD) or multicentric (MCD), and it can be classified into three...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  895 results

UCD with MCD-like inflammatory state: surgical excision is highly effective.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805307
Blood Advances; Zhang MY, Jia MN et. al.

Feb 11th, 2021 - Unicentric Castleman disease (UCD) is a rare lymphoproliferative disorder presenting as a single nodal mass with characteristic histopathology. Patients with UCD are typically asymptomatic with normal laboratory markers, whereas patients with mult...

Coexistence of disseminated Kaposi sarcoma and multicentric Castleman disease in an HIV...
https://doi.org/10.1177/0956462420968385
International Journal of STD & AIDS; Lin IF, Lin JN et. al.

Feb 8th, 2021 - Coexistence of multicentric Castleman disease and Kaposi sarcoma is rare and might be missed without an experienced pathologists' interpretation. A 46-year-old man had been diagnosed with HIV infection and treated with combination antiretroviral t...

Adult Langerhans cell histiocytosis of skull in a patient with synchronous papillary th...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839860
BMJ Case Reports; Kim IK, Lee KY

Jan 26th, 2021 - We report an extremely rare case of adult Langerhans cell histiocytosis (LCH) in a patient with papillary thyroid carcinoma (PTC) and Castleman disease (CD). A 46-year-old man visited our hospital with anaemia; systemic imaging showed an abdominal...

Cutaneous Involvement as Initial Presentation of Multicentric Plasmacytic Castleman Dis...
https://doi.org/10.1111/cup.13964
Journal of Cutaneous Pathology; Chen H, Ba W et. al.

Jan 20th, 2021 - Castleman disease (CD) is an unusual lymphoproliferative disorder characterized by multiple lymphadenopathy accompanied by marked systemic inflammatory symptoms. CD can be unicentric (UCD) or multicentric (MCD), and it can be classified into three...

see more →

News  11 results

New guidelines for idiopathic multicentric Castleman disease
https://www.mdedge.com/hematology-oncology/article/184660/related-issues/new-guidelines-idiopathic-multicentric-castleman-disease
Andrew D. Bowser

Oct 10th, 2018 - Photo from Penn Medicine David C. Fajgenbaum, MD The anti-IL-6 antibody siltuximab is central to first-line treatment of idiopathic multicentric Castleman disease (iMCD), according to new guidelines on iMCD published in Blood.

New guidelines frame treatment options for Castleman disease
https://www.mdedge.com/hematology-oncology/article/175993/patient-survivor-care/new-guidelines-frame-treatment-options
Andrew D. Bowser

Sep 28th, 2018 - The anti-interleukin-6 antibody siltuximab is central to first-line treatment of idiopathic multicentric Castleman disease (MCD), although adjuvant chemotherapy can be critical in severe cases, according to the first-ever consensus treatment guide.

Rare type of MCL mimics Castleman disease
https://www.mdedge.com/fedprac/article/148854/hematologic-malignancies/rare-type-mcl-mimics-castleman-disease
Andrew D. Bowser

Oct 6th, 2017 - A rare type of mantle cell lymphoma (MCL) has features that are similar to those of Castleman disease, according to a recent report based on three patient cases. Lymph node biopsies for these patients initially indicated histologic features consis.

Unicentric Castleman disease disguised as a pancreatic neoplasm
https://www.mdedge.com/hematology-oncology/article/126462/lymphoma-plasma-cell-disorders/unicentric-castleman-disease
Andrew McGregor et al

Dec 22nd, 2016 - Castleman disease or angiofollicular lymph node hyperplasia is an uncommon cause of an incidental abdominal mass found on imaging. The etiology of Castleman disease is relatively unknown, however, it is thought to be primarily associated with an o.

University of Pennsylvania Orphan Disease Center Posts RFPs
https://www.mdedge.com/familymedicine/article/113282/rare-diseases/university-pennsylvania-orphan-disease-center-posts-rfps
Neurology Reviews;

Sep 23rd, 2016 - Grants made possible by the “Million Dollar Bike Ride” and rare disease patient organizations are now available through the University of Pennsylvania Orphan Disease Center. September 16 is the deadline for letters of intent.

see more →

Patient Education  5 results see all →